Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot study-Reference-Cited by-同舟云学术

Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot study

Published:2017-07-02 Issue:2 Volume:177 Page:557-559
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Pandey K.¹,Pal B.²,Das V.N.R.¹,Murti K.²,Lal C.S.³,Verma N.⁴,Bimal S.⁵,Ali V.³,Verma R.B.⁶,Topno R.K.⁷,Siddiqi N.A.⁶,Das P.⁸

Affiliation:

1. Department of Clinical Medicine; Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research); Agamkuan Patna Bihar India

2. Department of Pharmacy Practice; National Institute of Pharmaceutical Education and Research; Hajipur Bihar India

3. Department of Biochemistry; Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research); Agamkuan Patna Bihar India

4. Department of Pathology; Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research); Agamkuan Patna Bihar India

5. Department of Immunology; Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research); Agamkuan Patna Bihar India

6. Department of Biostatistics; Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research); Agamkuan Patna Bihar India

7. Department of Epidemiology; Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research); Agamkuan Patna Bihar India

8. Department of Molecular Biology; Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research); Agamkuan Patna Bihar India

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.15119/fullpdf

Reference8 articles.

1. Efficacy and safety of miltefosine in treatment of post-kala-azar dermal leishmaniasis;Sundar;ScientificWorldJournal,2015

2. Post-kala-azar dermal leishmaniasis;Zijlstra;Lancet Infect Dis,2003

3. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non- inferiority, randomised controlled trial;Sundar;Lancet,2011

4. Quantitation of amastigotes of Leishmania donovani in smears of spleenic aspirates from patients with visceral leishmaniasis;Chulay;Am J Trop Med Hyg,1983

5. National Cancer Institute Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events v3.0 https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcaev3.pdf

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ophthalmic adverse effects of miltefosine in the treatment of leishmaniasis: a systematic review;Cutaneous and Ocular Toxicology;2024-07-02

2. Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform;PLOS Neglected Tropical Diseases;2024-04-16

3. Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: a systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform;2023-09-07

4. Barriers to the effective management and prevention of post kala-azar dermal leishmaniasis (PKDL) in the Indian subcontinent;Medical Journal Armed Forces India;2023-09

5. Post Kala-Azar Dermal Leishmaniasis: Diagnosis and Treatment;Challenges and Solutions Against Visceral Leishmaniasis;2023